stockrowiRhythm Holdings, Inc.
IRTC Healthcare Medical Devices
iRhythm Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $747.1 million, up 26.2% from fiscal 2024.
- Revenue
- +14.9%
- EPS
- −462.5%
- Free cash flow
- −157.6%
- Total debt
- +0.48%
Quarter to September 2026, against a year earlier
Follow IRTC
Alert me
iRhythm Holdings, Inc. (IRTC) Return on assets
iRhythm Holdings, Inc.'s return on assets over the twelve months to 30 September 2026 was −3.70%, up 0.9 percentage points from fiscal 2025 (−4.57%). Over the past ten years it has ranged from −80.9% (fiscal 2015) to −4.57% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −17.3% and above the Healthcare sector median of −29.3%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2025 | −4.57% | 12.03 |
| FY2024 | −16.6% | 11.40 |
| FY2023 | −28.0% | (2.50) |
| FY2022 | −25.5% | (4.70) |
| FY2021 | −20.8% | (10.08) |
| FY2020 | −10.7% | 15.04 |
| FY2019 | −25.8% | 14.44 |
| FY2018 | −40.2% | (18.27) |
| FY2017 | −21.9% | 1.82 |
| FY2016 | −23.8% | 57.12 |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| TMDX TransMedics Group, Inc. compare | 11.7% |
| UFPT UFP Technologies, Inc. compare | 11.5% |
| LIVN LivaNova PLC compare | 7.44% |
| HAE Haemonetics Corporation compare | 4.28% |
| ITGR Integer Holdings Corporation compare | 3.05% |
| NEOG Neogen Corporation compare | −1.68% |
| IRTC iRhythm Holdings, Inc. | −3.70% |
| TXG 10x Genomics compare | −7.47% |
| AXGN AxoGen, Inc. compare | −8.33% |
| Medical Devices industry median | −17.3% |
| Healthcare sector median | −29.3% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on IRTC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement